4.11 USD
↗ 0.04 (0.98%)AT CLOSE (03:59 PM EDT)
Unicycive Therapeutics, Inc. Common Stock
UNCYNASDAQ • USD
4.12
↗ 0.01 (0.12%)
POST MARKET (AS OF 07:31 PM EDT)
Post Market
AS OF 07:31 PM EDT
4.12
↗ 0.01 (0.12%)
Market: CLOSED
UNCY is currently priced at $4.11. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. Key drivers include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. On the valuation side, UNCY appears attractively valued relative to sector peers across key multiples.
Technical & fundamental data as of Oct 9, 2026.
Open?$4.07
High?$4.20
Low?$4.05
Prev. Close?$4.07
Volume?551.4K
Avg. Volume?872.0K
VWAP?$4.12
Rel. Volume?0.63x
Bid / Ask
Bid?$4.10 × 5.5K
Ask?$4.20 × 9.5K
Spread?$0.10
Midpoint?$4.15
Valuation & Ratios
Market Cap?114.5M
Shares Out?27.9M
Float?26.9M
Float %?98.2%
P/E Ratio?N/A
P/B Ratio?2.15
EPS?-$1.26
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Unicycive Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and commercializing therapies to address unmet medical needs, with a primary focus on kidney disease. The company is advancing two key product candidates: oxylanthanum carbonate (OLC), a phosphate binder for the treatment of hyperphosphatemia in chronic kidney disease patients on dialysis, and UNI-494, a drug candidate for the treatment of acute kidney injury.
Employees
22
Market Cap
114.5M
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2021-07-13
Address
1975 W. EL CAMINO REAL, SUITE 204
MOUNTAIN VIEW, CA 94040
Phone: 650-384-0642
MOUNTAIN VIEW, CA 94040
Phone: 650-384-0642
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-3/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?4
Momentum?65
Short Sent.?21
Piotroski F-Score?0/9Weak
Altman Z-Score?0.25Distress
Confidence?50%Low
Short InterestHigh
Short % of Float?18.05%High
Short Interest?4.9M
Days to Cover?5.7
Free Float26.9M
Avg Daily Volume846.0K
Settlement Date2026-09-30
Financial Health
Current Ratio?3.81Strong
Quick Ratio?3.81Strong
Cash Ratio?2.36Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?N/A▾
P/B?2.15CHEAP▾
Peers100
S&P71
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-2.1CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-66.1%WEAK▾
S&P3
ROA?-48.9%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-27848000
Enterprise Value?$70.3M
Fundamentals ratios updated end of day